EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS136-05277 
Organism
Homo sapiens 
Tissue/cell
Monocyte 
Coordinate
chr12:133020780-133023220 
TF binding sites/motifs
Number: 27             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC-6.92
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC-6.74
JDP2(var.2)MA0656.1chr12:133022644-133022656TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022745-133022757TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022695-133022707GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022796-133022808GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022847-133022859GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022897-133022909GATGACGTCACC+6.92
PRDM1MA0508.2chr12:133021450-133021460TCACTTTCAC+6.02
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10775chr12:133020028-133023469CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr12133021598133021727
chr12133021781133022391
chr12133021534133022956
Number: 1             
IDChromosomeStartEnd
GH12I132443chr12133020139133023744
Enhancer Sequence
GTCTTATTTT AAAGTGGCCG TCAGGGCCGA ATGTTCTGCC CATTTTGTCC ACACTAATTA 60
TCCCTCTTTG GGGAGCAAGA CCCTTGTGAG ATGCCACCGC CACCCTCGGG AGGCCTCCAG 120
GCTGGGGGAC GGGCACTGTG GGCTGCTGGT GTAGGGCCGG ACGCTCTCTG ACAGTGTTGC 180
CCCTGGCCTC CGGCGGCTTC CTCCCAAGCT GGGTTGGGGC TCTTCTGAAC GCTCCCCTCC 240
ATGCCCTGTC CTGGGAACTT TAACCCTCTG GGCCTCCCGG AGCCCTCTGT CTCCCCTGTC 300
CCAGGGGGTC TGCTGGGCTC CACCGGGCCC CGCCCTGAAT GCAGCCTGGA GCAACGCTGG 360
AGGCCGGGGC TAGGAAACTG TGAGCCCCGC CTTGTCTGTG TCTTTCTCAG GGATTCTCGT 420
CCTTTCCAAC CTGGTGCCCG ATGTCCGGAA GCACCTCTTC TGTGTTTTCA AATGGGAGAG 480
CGAATCCAGT CCTTTTCACT CCATTTTGGC CAGAAACAGA AGTCCTCCGT GATTTATATT 540
TTTACTAGAA TCTTTTAAAG GGGCACAAAT GGGGGTGTTT TGCAGGCATA CAGAAGCCCC 600
CGTCACTCCT CCCGCCTTGT CTCTGAACCG CTGTGGGGTG GGGAGGGGTC TCTTCTCTCT 660
CCAACCCACA TCACTTTCAC CCCCCGCCGG CCAAGGCTGC GTTTCCCTCG CCCCCACCCC 720
AGTCCCCCGC GTTGGTAGTG GGATCGGTTT GGTATTCTGA GGCTTCTCTC ATTTCTCCTT 780
TATCACCATC TGCCCCACAG CAGGCAGGCC CGGAGCCTCT GCAGAAGGGG GAACCGGGTG 840
CAGGCCCAAC GCCGGTCTCT CAGTGTGGCA GCCTTGCGCG CGAGCAGAAG CAGAAGGCCT 900
AGTTCCTACT CTGCAGCCTT GGCTGCCGGG CACGGAGAAC GTTTTAGCAG AAACACCTCT 960
GCAAAACCAC TTCCTGGCCC GGGCCCAGCC AAACACCATC TTCTCCTCCA CCCCAGGGCT 1020
CCGCCCCCAT CTCCAGGCTC AGCCCAGCAC CCCCACCCCC GAAACCCCCA GCCCCACTGC 1080
ATCTGCCCTG GCCATCTGCC TCCGCCCTGC CTCGCTAACA CAGTTATTAA TGAGCAATTT 1140
TCCTGTAATT ACAACGCAGT TATGCCAGTT ACCCCGACCT GCTGACAGAG AGCATTCACT 1200
TCCATGTGGC ACTAGCCCCC AGGCCTGAGA GGACGCAAAC ACTTGCCCCT CATTCGCTGC 1260
CCCCACCCCC ACTCTGCCAG CCAGCACCAC CCTCCACCCA CTCTAGGCCC TTAAGAAAGG 1320
AGGGAAGGGC CGCGGGGAGG AGCTCTCAGA TCCCGAGGCC CCACTCCCCC TGCAAGGAAG 1380
GCTGTGAGCT CGGCCCCAGC CCACCTGCCA GCTCCCCAAA CACCTCCCAC CTCCCTCCGC 1440
CGCCTCCTGA AGGGACTACA CTCCCCTGGC TCCTCCAAAA TCCGCTAATG AACAGCAGGC 1500
GCAGAGGCTC CGCCACCGGC GTGCTCCTGG CCTCAGCCCT CCCTGTTCTG AAACCGCCTT 1560
TGCTAAGACG GTAGTAGTGA GGAATCACGA CAGTGGCAGA GGCCAACCTG ACCCGCTCCA 1620
CCTGCCTCCA CCCCAACCCG CCCGGCTGCT TCCTGAGCGT GGGCCAAACT AACTTTGACA 1680
GGAACTTAGT TTACAGTTTA AGTTGGGAAC AAAAAGGATA ACAGCCCCTC CCCAAAACAG 1740
ATTCCCTCCT CGCTTGGGGG GACCAGTCCC GTTGTAAAAC CGACAAATAA CAGCAGGATT 1800
AGGAATTCCG GCTCAGGATT CACGCAGCCA GACGCCACAG GACTCCTCCC CAGCCGCTCC 1860
TGTATATGAC GTCACCGCCG TAAGACCACA GGACACCGCC CCAGCCGCGC CTGTAGATGA 1920
CGTCACCATC GTAAGACCAC AGGACCCTTC CCAGCCGCTC CTGTATATGA CGTCACCGCC 1980
GTAAGACCAC AAGTCACCGC CCCAGCCGCT CCTGTAGATG ACGTCACCAC AGTAAGACCA 2040
CAGGATACCG CCCCAGCCGC GCCTGTAGAT GACGTCACCA TCGTAGGCCC ACAGGACCCT 2100
TCCCAGCCGC TCCTGTGGAT GACGTCACCG CCGTAGGACC TAAGATTGAT GCTGGAGAGG 2160
TTCTTCAGAC CCTGCGTTCT GACGGCTCCG CTGGCACCAC CCAGACGGGT AAACTAGCTC 2220
TTCCGGTCTG TGGCCCTCAC AGGAACCGAC TCGGTGCAGG AGGACAGCTT CAGCCCCTGT 2280
GATTTCATCC CCGACCAACC AGCCAGCACT CCCCACTCCC TAGCCCCCTG CCTGCCAAAC 2340
TATCTTTTAA AAAACTCCAG TTTCCAAATT TTCAGGGAGG CTGATTTGAG TAATAATAAA 2400
ACTCCAGTCT CCTGCTAGCT GGCTCTGGAT GCACTAGACT 2440